Conmed Corp. - Ordinary Shares

128.32+3.29+2.63%Vol 278.52K1Y Perf 50.26%
Sep 15th, 2021 16:00 DELAYED
BID109.75 ASK0.0000
Open124.92 Previous Close125.03
Pre-Market- After-Market-
 - -%  - -
Target Price
156.83 
Analyst Rating
Moderate Buy 2.00
Potential %
22.22 
Finscreener Ranking
+     39.29
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
+     37.29
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★+     48.99
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     27.78
Price Range Ratio 52W %
75.91 
Earnings Rating
Sell
Market Cap3.74B 
Earnings Date
27th Oct 2021
Alpha0.00 Standard Deviation0.10
Beta1.58 

Today's Price Range

124.42129.09

52W Range

69.60146.95

5 Year PE Ratio Range

25.30119.80

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
0.58%
1 Month
1.69%
3 Months
-6.33%
6 Months
2.43%
1 Year
50.26%
3 Years
58.97%
5 Years
229.03%
10 Years
485.74%

TickerPriceChg.Chg.%
CNMD128.323.29002.63
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
1.10
2.20
0.49
0.98
2.30
Leverage Ratio 2.40
ProfitabilityValueIndustryS&P 500US Markets
55.10
10.20
17.60
4.10
5.70
RevenueValueIndustryS&P 500US Markets
978.50M
33.55
2.89
4.60
DividendsValueIndustryS&P 500US Markets
0.65
0.80
0.00
0.00
Payout ratio186.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.620.7114.52
Q01 20210.430.6346.51
Q04 20200.780.847.69
Q03 20200.250.88252.00
Q02 2020-1.02-0.0793.14
Q01 20200.440.5115.91
Q04 20190.890.901.12
Q03 20190.560.6210.71
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.77-9.41Negative
12/2021 QR1.071.90Positive
12/2021 FY3.191.27Positive
12/2022 FY3.780.80Positive
Next Report Date27th Oct 2021
Estimated EPS Next Report0.77
Estimates Count5
EPS Growth Next 5 Years %9.90
Volume Overview
Volume278.52K
Shares Outstanding29.16M
Shares Float21.37M
Trades Count7.15K
Dollar Volume30.92M
Avg. Volume253.31K
Avg. Weekly Volume194.45K
Avg. Monthly Volume186.72K
Avg. Quarterly Volume214.51K

Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 128.32 per share at the end of the most recent trading day (a 2.63% change compared to the prior day closing price) with a volume of 280.45K shares and market capitalization of 3.74B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is 50.26%, while year-to-date (YTD) performance is 14.57%. CNMD stock has a five-year performance of 229.03%. Its 52-week range is between 69.6 and 146.95, which gives CNMD stock a 52-week price range ratio of 75.91%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 69.10, a price-to-book (PB) ratio of 4.82, a price-to-sale (PS) ratio of 3.66, a price to cashflow ratio of 34.30, a PEG ratio of 2.32, a ROA of 3.02%, a ROC of 6.42% and a ROE of 7.43%. The company’s profit margin is 5.70%, its EBITDA margin is 17.60%, and its revenue ttm is $978.50 Million , which makes it $33.55 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.77 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 27th Oct 2021.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $156.83, which is +22.22% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.65% with a dividend per share of $0.80 and a payout ratio of 186.00%.

Conmed Corp. - Ordinary Shares has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.25, ATR14 : 3.36, CCI20 : -44.02, Chaikin Money Flow : 0.11, MACD : -1.27, Money Flow Index : 37.46, ROC : -4.56, RSI : 49.01, STOCH (14,3) : 51.42, STOCH RSI : 1.00, UO : 48.43, Williams %R : -48.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 90 377 shares of value $11 313 893 ), Daniel S. Jonas (Option Excercise at a value of $1 994 885), Daniel S. Jonas (Sold 36 600 shares of value $4 644 685 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $537 200), Heather L. Cohen (Sold 4 617 shares of value $655 220 ), Jerome J Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 676 626), John E. Kennedy (Sold 47 336 shares of value $4 875 514 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $349 257), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Todd W. Garner (Sold 3 567 shares of value $474 760 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
3 (50.00 %)
3 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (50.00 %)
3 (50.00 %)
3 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

Conmed Corp. - Ordinary Shares

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

CEO: Curt R. Hartman

Telephone: +1 727 392-6464

Address: 11311 Concept Boulevard, Largo 33773, FL, US

Number of employees: 3 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

53%48%

Bearish Bullish

50%50%

News

Stocktwits